N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration

被引：27

作者：

Shalansky, SJ

Pate, GE

Levin, A

Webb, JG

机构：

[1] St Pauls Hosp, Dept Pharm, Vancouver, BC V6Z 1Y6, Canada

[2] St Pauls Hosp, Div Cardiol, Vancouver, BC V6Z 1Y6, Canada

[3] St Pauls Hosp, Div Nephrol, Vancouver, BC V6Z 1Y6, Canada

[4] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada

来源：

HEART | 2005年 / 91卷 / 08期

关键词：

D O I：

10.1136/hrt.2004.053579

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：997 / 999

页数：3

共 15 条

[1] Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease:: A meta-analysis of randomized, controlled trials [J].

Alonso, A ;

Lau, J ;

Jaber, BL ;

Weintraub, A ;

Sarnak, MJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (01) :1-9

[2] A rapid protocol for the prevention of contrast - Induced renal dysfunction: the RAPPID study [J].

Baker, CSR ;

Wragg, A ;

Kumar, S ;

De Palma, R ;

Baker, LRI ;

Knight, CJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2114-2118

[3] Acetylcysteine for prevention of contrast nephropathy:: meta-analysis [J].

Birck, R ;

Krzossok, S ;

Markowetz, F ;

Schnülle, P ;

van der Woude, FJ ;

Braun, C .

LANCET, 2003, 362 (9384) :598-603

[4] PHARMACOKINETICS OF N-ACETYLCYSTEINE IN MAN [J].

BORGSTROM, L ;

KAGEDAL, B ;

PAULSEN, O .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :217-222

[5] Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity [J].

Briguori, C ;

Colombo, A ;

Violante, A ;

Balestrieri, P ;

Manganelli, F ;

Elia, PP ;

Golia, B ;

Lepore, S ;

Riviezzo, G ;

Scarpato, P ;

Focaccio, A ;

Librera, M ;

Bonizzoni, E ;

Ricciardelli, B .

EUROPEAN HEART JOURNAL, 2004, 25 (03) :206-211

[6] N-acetylcysteine in the prevention of radiocontrast-induced nephropathy [J].

Fishbane, S ;

Durham, JH ;

Marzo, K ;

Rudnick, M .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (02) :251-260

[7] Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency:: A randomized trial [J].

Fung, JWH ;

Szeto, CC ;

Chan, WWM ;

Kum, LCC ;

Chan, AKY ;

Wong, JTH ;

Wu, EB ;

Yip, GWK ;

Chan, JYS ;

Yu, CM ;

Woo, KS ;

Sanderson, JE .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (05) :801-808

[8] The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable [J].

Hoffmann, U ;

Fischereder, M ;

Krüger, B ;

Drobnik, W ;

Krämer, BK .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (02) :407-410

[9] Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy [J].

Isenbarger, DW ;

Kent, SM ;

O'Malley, PG .

AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (12) :1454-1458

[10] Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention - A randomized controlled trial [J].

Kay, J ;

Chow, WH ;

Chan, TM ;

Lo, SK ;

Kwok, OH ;

Yip, A ;

Fan, K ;

Lee, CH ;

Lam, WF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (05) :553-558

← 1 2 →